Block & Leviton Investigates FMC Corporation Over Unsold Distributor Inventory Claims

Block & Leviton is investigating FMC Corporation for potential securities law violations, alleging the company misled investors about how much higher-priced product sat unsold with distributors. The Boston-based firm announced the investigation on October 15, 2026, according to GlobeNewswire. FMC is a US agricultural sciences company that develops herbicides, insecticides, fungicides, biologicals and pheromone crop-protection products for growers in more than 35 countries.

FMC's October 15 Revenue and EBITDA Disclosure

FMC announced on October 15, 2026, about two weeks after the third quarter ended, that it expected quarterly revenue of only $65 million to $125 million and an Adjusted EBITDA loss of $510 million to $565 million. Those results included $625 million to $675 million in charges from cutting prices on FMC products already held by distributors and changing how it sells and prices products in the United States. FMC acknowledged it had been working through this inventory over several quarters. On its July 30, 2026 earnings call, the CEO reportedly blamed weak sales on weather, geopolitics and cautious buying without mentioning the inventory problem. After the October announcement, FMC's stock fell roughly 39%. Block & Leviton said it may file an action to attempt to recover losses on behalf of investors who have lost money, and that anyone who purchased FMC common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Aktien reported on October 15, 2026 that Block & Leviton is investigating Energy Fuels for potential securities law violations, citing a customer dispute with VAC that occurred before the $1.9 billion acquisition. The future of trading reported on October 13, 2026 that Block & Leviton announced a securities fraud lawsuit against Millrose Properties and its executives, alleging the company misled investors about its business model and transactions with Lennar.

FMC's Funding and Divestiture Records

According to akta.pro company records, FMC's full-year 2025 revenue was $3.47 billion, down 18% versus 2024, and its full-year 2026 guidance is $3.60 billion to $3.80 billion. The same records show a 2026-06 post-IPO equity round of $400 million led by Tessenderlo and a 2026-05 post-IPO debt round of $1.2 billion. FMC's total funding stands at $1.6 billion, with the last round dated 2026-06-30.

FMC's Path to the October Announcement

FMC announced on September 21, 2026 that it would release its third quarter 2026 earnings on October 29, 2026, after market close, with a public webcast conference call on October 30, 2026, at 9:00 a.m. ET, according to Stock Titan. Tessenderlo Group closed a minority equity investment in FMC on September 23, 2026, purchasing 30,319,166 shares at $13.30 per share for approximately $403 million, Stock Titan reported. FMC submitted a regulatory dossier for rimisoxafen to Brazilian authorities on September 28, 2026, the second global filing for the dual mode of action herbicide, following the U.S. filing, PR Newswire reported.

FMC's October 29 Earnings Release

FMC will release its third quarter 2026 earnings on October 29, 2026, after market close, and will host a public webcast conference call on October 30, 2026, at 9:00 a.m. ET.